125 related articles for article (PubMed ID: 38642607)
1. Deciphering a GPCR-lncrna-miRNA nexus: Identification of an aberrant therapeutic target in ovarian cancer.
Ha JH; Radhakrishnan R; Nadhan R; Gomathinayagam R; Jayaraman M; Yan M; Kashyap S; Fung KM; Xu C; Bhattacharya R; Mukherjee P; Isidoro C; Song YS; Dhanasekaran DN
Cancer Lett; 2024 Jun; 591():216891. PubMed ID: 38642607
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells.
Pan J; Li X; Wu W; Xue M; Hou H; Zhai W; Chen W
Cancer Lett; 2016 Nov; 382(1):64-76. PubMed ID: 27591936
[TBL] [Abstract][Full Text] [Related]
3. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
4. Proto-oncogene c-Myb potentiates cisplatin resistance of ovarian cancer cells by downregulating lncRNA NKILA and modulating cancer stemness and LIN28A-let7 axis.
Zhang XY; Zhu BC; He M; Dong SS
J Ovarian Res; 2024 May; 17(1):102. PubMed ID: 38745302
[TBL] [Abstract][Full Text] [Related]
5. Long Non-coding RNA UCA1 Regulates SRPK1 Expression Through miR- 99b-3p in Ovarian Cancer.
Xu J; Zheng LH; Hong YN; Xuan C; Yan SL; Lv GL; Jiang ZG; Ding XF
Protein Pept Lett; 2022; 29(10):829-838. PubMed ID: 35794743
[TBL] [Abstract][Full Text] [Related]
6. UCA1 confers paclitaxel resistance to ovarian cancer through miR-129/ABCB1 axis.
Wang J; Ye C; Liu J; Hu Y
Biochem Biophys Res Commun; 2018 Jul; 501(4):1034-1040. PubMed ID: 29777711
[TBL] [Abstract][Full Text] [Related]
7. Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving.
Wang DY; Li N; Cui YL
Cancer Res Treat; 2020 Jul; 52(3):798-814. PubMed ID: 32124583
[TBL] [Abstract][Full Text] [Related]
8. The lncRNA 'UCA1' modulates the response to chemotherapy of ovarian cancer through direct binding to miR-27a-5p and control of UBE2N levels.
Wambecke A; Ahmad M; Morice PM; Lambert B; Weiswald LB; Vernon M; Vigneron N; Abeilard E; Brotin E; Figeac M; Gauduchon P; Poulain L; Denoyelle C; Meryet-Figuiere M
Mol Oncol; 2021 Dec; 15(12):3659-3678. PubMed ID: 34160887
[TBL] [Abstract][Full Text] [Related]
9. Novel role of lncRNA CHRF in cisplatin resistance of ovarian cancer is mediated by miR-10b induced EMT and STAT3 signaling.
Tan WX; Sun G; Shangguan MY; Gui Z; Bao Y; Li YF; Jia ZH
Sci Rep; 2020 Sep; 10(1):14768. PubMed ID: 32901049
[TBL] [Abstract][Full Text] [Related]
10. The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation.
Wang H; Fang L; Jiang J; Kuang Y; Wang B; Shang X; Han P; Li Y; Liu M; Zhang Z; Li P
Cell Death Dis; 2018 Oct; 9(11):1103. PubMed ID: 30375398
[TBL] [Abstract][Full Text] [Related]
11. LPA3 is a precise therapeutic target and potential biomarker for ovarian cancer.
Zhao P; Yun Q; Li A; Li R; Yan Y; Wang Y; Sun H; Damirin A
Med Oncol; 2022 Jan; 39(2):17. PubMed ID: 34982278
[TBL] [Abstract][Full Text] [Related]
12. Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism.
Seo EJ; Kwon YW; Jang IH; Kim DK; Lee SI; Choi EJ; Kim KH; Suh DS; Lee JH; Choi KU; Lee JW; Mok HJ; Kim KP; Matsumoto H; Aoki J; Kim JH
Stem Cells; 2016 Mar; 34(3):551-64. PubMed ID: 26800320
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA UCA1 promotes malignant phenotypes of renal cancer cells by modulating the miR-182-5p/DLL4 axis as a ceRNA.
Wang W; Hu W; Wang Y; An Y; Song L; Shang P; Yue Z
Mol Cancer; 2020 Jan; 19(1):18. PubMed ID: 31996265
[TBL] [Abstract][Full Text] [Related]
14. LncRNA UCA1 promotes development of gastric cancer via the miR-145/MYO6 axis.
Yang A; Liu X; Liu P; Feng Y; Liu H; Gao S; Huo L; Han X; Wang J; Kong W
Cell Mol Biol Lett; 2021 Jul; 26(1):33. PubMed ID: 34238213
[TBL] [Abstract][Full Text] [Related]
15. Urothelial carcinoma associated 1 is a hypoxia-inducible factor-1α-targeted long noncoding RNA that enhances hypoxic bladder cancer cell proliferation, migration, and invasion.
Xue M; Li X; Li Z; Chen W
Tumour Biol; 2014 Jul; 35(7):6901-12. PubMed ID: 24737584
[TBL] [Abstract][Full Text] [Related]
16. LncRNA ANRIL affects the sensitivity of ovarian cancer to cisplatin via regulation of let-7a/HMGA2 axis.
Miao JT; Gao JH; Chen YQ; Chen H; Meng HY; Lou G
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31189742
[TBL] [Abstract][Full Text] [Related]
17. LncRNA-UCA1 exerts oncogenic functions in non-small cell lung cancer by targeting miR-193a-3p.
Nie W; Ge HJ; Yang XQ; Sun X; Huang H; Tao X; Chen WS; Li B
Cancer Lett; 2016 Feb; 371(1):99-106. PubMed ID: 26655272
[TBL] [Abstract][Full Text] [Related]
18. Suppression of long non-coding RNA UCA1 inhibits proliferation and invasion and induces apoptosis in human lung cancer cells.
Jun T; Zheng FS; Ren KM; Zhang HY; Zhao JG; Zhao JZ
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7274-7281. PubMed ID: 30468471
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-302 represses epithelial-mesenchymal transition and cisplatin resistance by regulating ATAD2 in ovarian carcinoma.
Ge T; Liu T; Guo L; Chen Z; Lou G
Exp Cell Res; 2020 Nov; 396(1):112241. PubMed ID: 32835657
[TBL] [Abstract][Full Text] [Related]
20. The long non-coding RNA, urothelial carcinoma associated 1, promotes cell growth, invasion, migration, and chemo-resistance in glioma through Wnt/β-catenin signaling pathway.
Zhang B; Fang S; Cheng Y; Zhou C; Deng F
Aging (Albany NY); 2019 Oct; 11(19):8239-8253. PubMed ID: 31596734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
